In vitro inhibition of mumps virus by retinoids

Kaitlin J. Soye, Claire Trottier, Thomas Z. Di Lenardo, Katherine H. Restori, Lee Reichman, Wilson H. Miller, Brian J. Ward

Research output: Contribution to journalArticlepeer-review

16 Scopus citations

Abstract

Background: Mumps virus (MuV) is a highly infectious paramyxovirus closely related to measles virus (MeV). Despite the availability of a mumps vaccine, outbreaks continue to occur and no treatment options are available. Vitamin A and other naturally occurring retinoids inhibit the replication of MeV in vitro. Methods. Anti-viral effects of retinoids were observed in cell culture using the myelomonocytic U937, NB4/R4, and Huh7/7.5 cells. Observations of anti-viral effect were quantified using TCID50 analysis. Molecular properties of the antiviral effect were analysed using quantitative RT-PCR and western blot. Results: The current work demonstrates that retinoids inhibit MuV in vitro due to up-regulation of type I interferon (IFN) and IFN stimulated genes. This effect is mediated by nuclear retinoid receptor signalling and RIG-I is required. The antiviral retinoid-induced state makes cells less permissive to viral replication from subsequent challenge with either MuV or MeV for less than 12 hours. Conclusions: These results demonstrate that retinoids inhibit MuV replication in uninfected bystander cells through a retinoid inducible gene I (RIG-I), retinoic acid receptor (RAR) and IFN dependent manner making them refractory to subsequent rounds of viral replication. These observations raise the possibility that pharmacological doses of retinoids might have clinical benefit in MuV infection.

Original languageEnglish (US)
Article number337
JournalVirology Journal
Volume10
DOIs
StatePublished - 2013

All Science Journal Classification (ASJC) codes

  • Virology
  • Infectious Diseases

Cite this